Healthtech Startups
17,195 companies tagged Healthtech, with their investors and founders.
0 investors
Beyond Air develops medical devices for respiratory treatment, serving healthcare providers and patients.
0 investors
0 investors
BG Medicine develops and commercializes cardiovascular diagnostic tests to assess heart failure risk and predict cardiovascular events. The company serves patients and healthcare providers seeking to improve diagnostic accuracy and patient outcomes in cardiology.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Bio Usawa is a biotechnology company that develops and manufactures affordable monoclonal antibodies and biologic medicines, with a focus on bringing cancer and other therapies to patients in Africa and globally.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
The BioCollective develops microbiome research tools, including a whole-stool BioCollector Kit, a fecal sample bank, and the Bioflux computational metabolic model used to build and evaluate probiotic consortia. Its products and reference materials serve research institutions, biotherapeutics companies, and probiotic developers, and it also produces the BiotiQuest consumer probiotic brand.
0 investors
0 investors
BioCytics conducts translational cancer research, including a project with UNC Charlotte and Carolina BioOncology Institute to study the "dark genome" of cancer cells to identify sequences involved in tumor growth, immune response, and treatment response. Its work spans cell therapy, neoantigens, tumor infiltrating lymphocytes, and clinical research informatics.
0 investors
0 investors
Biodynamik is a medical device company developing orthopedic-driven regenerative technologies, including its XT3 System for treating diabetic foot ulcers. The company is pursuing U.S. clinical trials under FDA IDE approval.
0 investors
BioFactura is a clinical-stage biopharmaceutical company developing biologics and biosimilars, and has launched Capitol Biologics, a CDMO division offering contract development and manufacturing services to advance biologics from concept to clinic.
0 investors
0 investors